[CBAY] YoY Quarter Result on 31-Mar-2022 [#Q1]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
12-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -16.93%
YoY- -76.83%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 0 0 0 0 0 0 4,793 -
PBT -28,778 -27,769 -17,551 -13,088 -23,075 -17,005 -5,351 32.34%
Tax 6,306 3,267 0 -768 1,176 -4,447 -1,829 -
NP -35,084 -31,036 -17,551 -13,088 -23,075 -17,005 -5,351 36.78%
Tax Rate - - - - - - - -
Total Cost 35,084 31,036 17,551 13,088 23,075 17,005 10,144 22.96%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -111.64 -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.36 -0.36 -0.25 -0.19 -0.37 -0.32 -0.20 10.28%
EPS Diluted -0.36 -0.35 -0.25 -0.19 -0.37 -0.32 -0.20 10.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.